粗针活检在先前细针穿刺结果不确定的甲状腺结节中的作用:系统评价与Meta分析
该系统评价与Meta分析纳入9项研究共2240例患者2245个甲状腺结节,评估粗针活检对先前细针穿刺细胞学结果不确定结节诊断的有效性和安全性。粗针活检无诊断结果率为1.8%(95%CI 0.4%-3.2%),不确定结果率为25.1%(95%CI 15.4%-34.9%),恶性比例为18.9%(95%CI 8.4%-29.5%);诊断恶性的敏感度范围为44.7%至85.0%,特异度在所有研究中均为100%,未观察到主要并发症。作者结论认为粗针活检无诊断结果率低、诊断恶性特异度高,是一种安全的诊断技术,诊断产出较高,尤其当分子检测不可用或细针穿刺未获得足够细胞进行分子检测时。
要点
- 粗针活检对细针穿刺结果不确定的甲状腺结节无诊断结果率仅1.8%。
- 粗针活检诊断恶性的特异度在所有纳入研究中均为100%,敏感度范围为44.7%至85.0%。
- 粗针活检未观察到主要并发症,但不确定结果率仍达25.1%。
核心结论
- 粗针活检对细针穿刺结果不确定的甲状腺结节具有低无诊断结果率和高诊断恶性特异度,是一种安全的诊断技术,诊断产出较高,尤其当分子检测不可用或细针穿刺未获得足够细胞进行分子检测时。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE和Embase数据库,纳入9项研究共2240例患者2245个甲状腺结节,采用随机效应模型进行Meta分析汇总。
诊断标准与关键数值
- 粗针活检无诊断结果汇总比例为1.8%(95%CI 0.4%-3.2%);不确定结果汇总比例为25.1%(95%CI 15.4%-34.9%);恶性汇总比例为18.9%(95%CI 8.4%-29.5%);诊断恶性的敏感度范围为44.7%至85.0%,特异度在所有研究中均为100%。
临床应用与阅片要点
- 作者结论认为粗针活检无诊断结果率低、诊断恶性特异度高,是一种安全的诊断技术,诊断产出较高,尤其当分子检测不可用或细针穿刺未获得足够细胞进行分子检测时。
局限性
- 纳入研究数量相对较少。
- 纳入研究为回顾性性质。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Sonography-guided fine-needle aspiration leads to relatively frequent cases of indeterminate cytology for the diagnosis of thyroid nodules.
PURPOSE: Our aim was to evaluate the efficacy and safety of core needle biopsy for the examination of thyroid nodules with initially indeterminate results on fine-needle aspiration.
DATA SOURCES: A computerized search of the MEDLINE and Embase databases was performed to identify relevant original articles.
STUDY SELECTION: Studies investigating the use of core needle biopsy for thyroid nodules with initially indeterminate results on previous fine-needle aspiration were eligible for inclusion.
DATA ANALYSIS: The pooled proportions for nondiagnostic results, inconclusive results, malignancy on core needle biopsy, the ability of core needle biopsy to diagnose malignancy, and the related complications of the procedure were analyzed.
DATA SYNTHESIS: The meta-analytic pooling was based on a random-effects model. Nine eligible studies, involving 2240 patients with 2245 thyroid nodules, were included. The pooled proportion for nondiagnostic results was 1.8% (95% CI, 0.4%-3.2%), and the pooled proportion for inconclusive results was 25.1% (95% CI, 15.4%-34.9%). The pooled proportion for malignancy was 18.9% (95% CI, 8.4%-29.5%). With regard to the diagnostic performance for malignancy, the sensitivity of core needle biopsy varied, ranging from 44.7% to 85.0%, but the specificity was 100% in all cases. No major complications of core needle biopsy were observed.
LIMITATIONS: The relatively small number of included studies and retrospective nature were limitations.
CONCLUSIONS: Core needle biopsy has low nondiagnostic result rates and high specificity for the diagnosis of malignancy. It is a safe diagnostic technique with a higher diagnostic yield, especially when molecular testing is not available or fine-needle aspiration did not yield enough cells for molecular testing.
引用
- Suh CH, Baek JH, Park C, et al. The Role of Core Needle Biopsy for Thyroid Nodules with Initially Indeterminate Results on Previous Fine-Needle Aspiration: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2017. PMID: 28473343. doi:10.3174/ajnr.A5182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。